Compile Data Set for Download or QSAR
Report error Found 74 Enz. Inhib. hit(s) with all data for entry = 50032485
TargetCytochrome P450 3A4(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50330005(N-(3,5-dimethylphenyl)-2-(4-(furan-2-ylmethyl)-5-(...)
Affinity DataIC50: 2.00E+3nMAssay Description:Inhibition of CYP3A4 using DEF substrate by CYPEX bactosome P450 inhibition assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2C9(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50330005(N-(3,5-dimethylphenyl)-2-(4-(furan-2-ylmethyl)-5-(...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of CYP2C9 by CYPEX bactosome P450 inhibition assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2C19(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50330005(N-(3,5-dimethylphenyl)-2-(4-(furan-2-ylmethyl)-5-(...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of CYP2C19 by CYPEX bactosome P450 inhibition assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 2D6(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50330005(N-(3,5-dimethylphenyl)-2-(4-(furan-2-ylmethyl)-5-(...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of CYP2D6 by CYPEX bactosome P450 inhibition assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 3A4(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50330005(N-(3,5-dimethylphenyl)-2-(4-(furan-2-ylmethyl)-5-(...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of CYP3A4 by CYPEX bactosome P450 inhibition assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetCytochrome P450 1A2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50330005(N-(3,5-dimethylphenyl)-2-(4-(furan-2-ylmethyl)-5-(...)
Affinity DataIC50: 5.00E+3nMAssay Description:Inhibition of CYP1A2 by CYPEX bactosome P450 inhibition assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin/Hypocretin receptor type 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417257(SB-649868)
Affinity DataKi:  0.316nMAssay Description:Antagonist activity against human orexin 1 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin receptor type 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417257(SB-649868)
Affinity DataKi:  0.398nMAssay Description:Antagonist activity against human orexin 2 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin receptor type 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50330005(N-(3,5-dimethylphenyl)-2-(4-(furan-2-ylmethyl)-5-(...)
Affinity DataKi:  1.58nMAssay Description:Antagonist activity against human orexin 2 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin receptor type 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417244(CHEMBL1271490)
Affinity DataKi:  2.51nMAssay Description:Antagonist activity against human orexin 2 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin receptor type 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417231(CHEMBL1271649)
Affinity DataKi:  15.8nMAssay Description:Antagonist activity against human orexin 2 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin receptor type 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417233(CHEMBL1272043)
Affinity DataKi:  31.6nMAssay Description:Antagonist activity against human orexin 2 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin receptor type 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417256(CHEMBL1271702)
Affinity DataKi:  39.8nMAssay Description:Antagonist activity against human orexin 2 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin receptor type 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417239(CHEMBL1271650)
Affinity DataKi:  39.8nMAssay Description:Antagonist activity against human orexin 2 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin receptor type 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417232(CHEMBL1271760)
Affinity DataKi:  50.1nMAssay Description:Antagonist activity against human orexin 2 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin receptor type 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417236(CHEMBL1271933)
Affinity DataKi:  63.1nMAssay Description:Antagonist activity against human orexin 2 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin receptor type 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417255(CHEMBL1272150)
Affinity DataKi:  100nMAssay Description:Antagonist activity against human orexin 2 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin receptor type 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417235(CHEMBL1271878)
Affinity DataKi:  100nMAssay Description:Antagonist activity against human orexin 2 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin receptor type 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417243(CHEMBL1272095)
Affinity DataKi:  158nMAssay Description:Antagonist activity against human orexin 2 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin receptor type 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417254(CHEMBL1271819)
Affinity DataKi:  158nMAssay Description:Antagonist activity against human orexin 2 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin receptor type 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417253(CHEMBL1271989)
Affinity DataKi:  200nMAssay Description:Antagonist activity against human orexin 2 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin receptor type 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417252(CHEMBL1271990)
Affinity DataKi:  251nMAssay Description:Antagonist activity against human orexin 2 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin receptor type 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417230(CHEMBL1272044)
Affinity DataKi:  316nMAssay Description:Antagonist activity against human orexin 2 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin receptor type 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417249(CHEMBL1271543)
Affinity DataKi:  398nMAssay Description:Antagonist activity against human orexin 2 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin receptor type 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417250(CHEMBL1272151)
Affinity DataKi:  398nMAssay Description:Antagonist activity against human orexin 2 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin receptor type 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417251(CHEMBL1272308)
Affinity DataKi:  398nMAssay Description:Antagonist activity against human orexin 2 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin receptor type 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417246(CHEMBL1271542)
Affinity DataKi:  501nMAssay Description:Antagonist activity against human orexin 2 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin receptor type 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417247(CHEMBL1271820)
Affinity DataKi:  501nMAssay Description:Antagonist activity against human orexin 2 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin receptor type 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417248(CHEMBL1271934)
Affinity DataKi:  501nMAssay Description:Antagonist activity against human orexin 2 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin/Hypocretin receptor type 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417244(CHEMBL1271490)
Affinity DataKi:  631nMAssay Description:Antagonist activity against human orexin 1 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin receptor type 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417245(CHEMBL1271491)
Affinity DataKi:  631nMAssay Description:Antagonist activity against human orexin 2 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin/Hypocretin receptor type 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417243(CHEMBL1272095)
Affinity DataKi:  794nMAssay Description:Antagonist activity against human orexin 1 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin/Hypocretin receptor type 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50330005(N-(3,5-dimethylphenyl)-2-(4-(furan-2-ylmethyl)-5-(...)
Affinity DataKi:  794nMAssay Description:Antagonist activity against human orexin 1 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin/Hypocretin receptor type 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417239(CHEMBL1271650)
Affinity DataKi:  1.00E+3nMAssay Description:Antagonist activity against human orexin 1 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin receptor type 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417242(CHEMBL1272206)
Affinity DataKi:  1.00E+3nMAssay Description:Antagonist activity against human orexin 2 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin receptor type 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417241(CHEMBL1272096)
Affinity DataKi:  1.00E+3nMAssay Description:Antagonist activity against human orexin 2 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin receptor type 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417240(CHEMBL1271701)
Affinity DataKi:  1.00E+3nMAssay Description:Antagonist activity against human orexin 2 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin/Hypocretin receptor type 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417246(CHEMBL1271542)
Affinity DataKi:  1.26E+3nMAssay Description:Antagonist activity against human orexin 1 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin receptor type 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417238(CHEMBL1272205)
Affinity DataKi:  1.58E+3nMAssay Description:Antagonist activity against human orexin 2 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin receptor type 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417237(CHEMBL1272309)
Affinity DataKi:  2.00E+3nMAssay Description:Antagonist activity against human orexin 2 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin/Hypocretin receptor type 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417236(CHEMBL1271933)
Affinity DataKi:  2.00E+3nMAssay Description:Antagonist activity against human orexin 1 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin/Hypocretin receptor type 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417235(CHEMBL1271878)
Affinity DataKi:  2.00E+3nMAssay Description:Antagonist activity against human orexin 1 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin receptor type 2(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417234(CHEMBL1271877)
Affinity DataKi:  2.00E+3nMAssay Description:Antagonist activity against human orexin 2 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin/Hypocretin receptor type 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417231(CHEMBL1271649)
Affinity DataKi:  2.51E+3nMAssay Description:Antagonist activity against human orexin 1 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin/Hypocretin receptor type 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417233(CHEMBL1272043)
Affinity DataKi:  2.51E+3nMAssay Description:Antagonist activity against human orexin 1 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin/Hypocretin receptor type 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417232(CHEMBL1271760)
Affinity DataKi:  2.51E+3nMAssay Description:Antagonist activity against human orexin 1 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin/Hypocretin receptor type 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417230(CHEMBL1272044)
Affinity DataKi:  3.16E+3nMAssay Description:Antagonist activity against human orexin 1 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin/Hypocretin receptor type 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417250(CHEMBL1272151)
Affinity DataKi: >1.58E+4nMAssay Description:Antagonist activity against human orexin 1 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin/Hypocretin receptor type 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417241(CHEMBL1272096)
Affinity DataKi: >1.58E+4nMAssay Description:Antagonist activity against human orexin 1 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
TargetOrexin/Hypocretin receptor type 1(Human)
Glaxosmithkline

Curated by ChEMBL
LigandPNGBDBM50417251(CHEMBL1272308)
Affinity DataKi: >1.58E+4nMAssay Description:Antagonist activity against human orexin 1 receptor expressed in CHO cells assessed as effect in calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
PubMed
Displayed 1 to 50 (of 74 total ) | Next | Last >>
Jump to: